Reshma Rangwala
Chief Tech/Sci/R&D Officer bij KARYOPHARM THERAPEUTICS INC.
Vermogen: 517 826 $ op 31-03-2024
Profiel
Reshma Rangwala is currently the Chief Medical Officer & Executive Vice President at Karyopharm Therapeutics, Inc. Prior to this, she held positions as the Executive Clinical Director at Merck & Co., Inc. from 2012 to 2017, Vice President-Medical at Genmab, Inc. from 2017 to 2020, and Chief Medical Officer at Aravive, Inc. from 2020 to 2022.
Dr. Rangwala completed her undergraduate degree at Duke University and obtained her doctorate from The University of Cincinnati College of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-04-2024 | 342 931 ( 0.30% ) | 517 826 $ | 31-03-2024 |
Actieve functies van Reshma Rangwala
| Bedrijven | Functie | Begin |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01-04-2022 |
Eerdere bekende functies van Reshma Rangwala
| Bedrijven | Functie | Einde |
|---|---|---|
| ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | 28-03-2022 |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 01-07-2020 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01-05-2017 |
Opleiding van Reshma Rangwala
| Duke University | Undergraduate Degree |
| The University of Cincinnati College of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Commercial Services |
